XML 23 R9.htm IDEA: XBRL DOCUMENT
v3.25.3

Fair Value Measurements | 9 Months Ended
--- | ---
Sep. 30, 2025
Fair Value Disclosures [Abstract] |
Fair Value Measurements |
2. Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis We estimate the fair values of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments. We obtain the fair values of our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We estimate the fair values of our Level 3 financial instruments based on unobservable inputs and other estimation techniques due to the absence of quoted market prices and inherent lack of liquidity. The following table summarizes financial assets that we measured at fair value on a recurring basis as of September 30, 2025, classified in accordance with the fair value hierarchy:
| Fair Value Measurements Using
(In millions) | Level 1 |  | Level 2 |  | Level 3 |  | Total
Cash equivalents | $ | 1,005.3 |  |  | $ | 367.9 |  |  | $ | — |  |  | $ | 1,373.2 |
Debt securities, available-for-sale: |  |  |  |  |  |  |
U.S. government agencies (1) | — |  |  | 648.6 |  |  | — |  |  | 648.6 |
Commercial paper | — |  |  | 172.2 |  |  | — |  |  | 172.2 |
Corporate debt | — |  |  | 665.6 |  |  | — |  |  | 665.6 |
Total debt securities, available-for-sale | — |  |  | 1,486.4 |  |  | — |  |  | 1,486.4 |
Other long-term assets: |  |  |  |  |  |  |
Convertible notes receivable | — |  |  | — |  |  | 10.5 |  |  | 10.5 |
Other assets (2) | 20.5 |  |  | — |  |  | — |  |  | 20.5 |
Total assets measured at fair value on a recurring basis | $ | 1,025.8 |  |  | $ | 1,854.3 |  |  | $ | 10.5 |  |  | $ | 2,890.6 |
(1)Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies. (2)Includes assets which are primarily held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds. The following table summarizes financial assets that we measured at fair value on a recurring basis as of December 31, 2024, classified in accordance with the fair value hierarchy:
| Fair Value Measurements Using
(In millions) | Level 1 |  | Level 2 |  | Level 3 |  | Total
Cash equivalents | $ | 134.2 |  |  | $ | — |  |  | $ | — |  |  | $ | 134.2 |
Debt securities, available-for-sale: |  |  |  |  |  |  |
U.S. government agencies (1) | — |  |  | 1,150.1 |  |  | — |  |  | 1,150.1 |
Commercial paper | — |  |  | 312.1 |  |  | — |  |  | 312.1 |
Corporate debt | — |  |  | 511.1 |  |  | — |  |  | 511.1 |
Total debt securities, available-for-sale | — |  |  | 1,973.3 |  |  | — |  |  | 1,973.3 |
Other long-term assets: |  |  |  |  |  |  |
Convertible notes receivable | — |  |  | — |  |  | 10.5 |  |  | 10.5 |
Other assets (2) | 20.6 |  |  | — |  |  | — |  |  | 20.6 |
Total assets measured at fair value on a recurring basis | $ | 154.8 |  |  | $ | 1,973.3 |  |  | $ | 10.5 |  |  | $ | 2,138.6 |
(1)Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies. (2)Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds. There were no transfers into or out of Level 3 securities during the three and nine months ended September 30, 2025 and September 30, 2024. Fair Value of Senior Convertible Notes The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:
| Fair Value Measurements Using Level 1
(In millions) | September 30, 2025 |  | December 31, 2024
Senior Convertible Notes due 2025 | $ | 1,199.6 |  |  | $ | 1,163.7 |
Senior Convertible Notes due 2028 | 1,140.4 |  |  | 1,122.3 |
Total fair value of outstanding senior convertible notes | $ | 2,340.0 |  |  | $ | 2,286.0 |
See Note 4 “Debt—Senior Convertible Notes” to the condensed consolidated financial statements for more information regarding the carrying values of our senior convertible notes. Foreign Currency and Derivative Financial Instruments As we conduct business globally in many currencies, we are exposed to foreign exchange rate changes. To limit this exposure, we enter into foreign currency forward contracts to hedge monetary assets and liabilities, including intercompany loans, denominated in non-functional currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts are generally one to three months. The derivative gains and losses are included in other income, net in our condensed consolidated statements of operations. As of September 30, 2025 and December 31, 2024, the notional amounts of outstanding foreign currency forward contracts were $214.0 million and $66.0 million, respectively. The resulting impact on our condensed consolidated financial statements from currency hedging activities was not significant for the three and nine months ended September 30, 2025 and September 30, 2024. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk. Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized. Our non-marketable equity investments without readily determinable fair values are accounted for under the measurement alternative. As such, we measure these investments at cost less impairment, adjusted for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We include the carrying values of these investments in other assets in our condensed consolidated balance sheets. Adjustments to the carrying values of these investments as a result of observable price changes and impairments are recorded in other income, net in our condensed consolidated statements of operations. The carrying values of the non-marketable equity investments were $216.9 million as of September 30, 2025 and $119.3 million as of December 31, 2024. During the three and nine months ended September 30, 2025, we recorded upward adjustments of $82.5 million for observable price changes. There were no significant impairment losses on assets and liabilities measured at fair value on a non-recurring basis during the three and nine months ended September 30, 2025 and September 30, 2024.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent + Details
Name: | us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration